Reyon Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
The page contains a questions and answers table about Reyon Pharmaceutical Co Ltd. The Disclosure rating covers seventeen United Nations Sustainable Development Goals including: 'Quality Education', 'Responsible Production & Consumption' and 'Life below Water'. Alternative corporations in the rating industry group for Reyon Pharmaceutical Co Ltd are displayedin the table.
Reyon Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.5; made up of an environmental score of 1.6, social score of 1.6 and governance score of 1.3.
1.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2329 | Veritas Pharma Inc | 1.6 | Low |
| 2329 | Zhejiang Xinguang Pharmaceutical Co Ltd | 1.6 | Low |
| 2372 | Reyon Pharmaceutical Co Ltd | 1.5 | Low |
| 2372 | Ambrx Biopharma Inc | 1.5 | Low |
| 2372 | Aikido Pharma Inc | 1.5 | Low |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Reyon Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd offer flexible work?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose water use targets?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Reyon Pharmaceutical Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Reyon Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs Reyon Pharmaceutical Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Reyon Pharmaceutical Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Reyon Pharmaceutical Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Reyon Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular system drugs; neuromuscular disorder related drugs; nootropics and neurotonics; NSAIDs; respiratory stimulants; skeletal muscle relaxants; and vasodilators. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.